\-\ Texto\\:\\ \ \(0\)\
\-\ patient\\ had\\ elevated\\ prolactin\\ levels\\ \\(22\\.5\\ ng\\/ml\\;\\ normal\\ 3\\-18\\.6\\)\\,\\ as\\ well\\ as\\ a\\ slightly\\ elevated\\ estradiol\\ level\\ \\(15\\ pg\\/ml\\)\\.\\ an\\ lrf\\ stimulation\\ test\\ with\\ leuprolide\\ acetate\\ \\(synthetic\\ gonadotropin\\-releasing\\ hormone\\)\\ was\\ ordered\\ to\\ rule\\ out\\ precocious\\ puberty\\,\\ and\\ an\\ mri\\ was\\ ordered\\ to\\ rule\\ out\\ pituitary\\ adenoma\\.\\ a\\ neurology\\/oncology\\ clinic\\ was\\ consulted\\,\\ and\\ at\\ the\\ time\\ the\\ prolactin\\ and\\ estradiol\\ levels\\ had\\ returned\\ to\\ normal\\.\\ however\\,\\ the\\ alpha\\ fetal\\ protein\\ levels\\ were\\ mildly\\ elevated\\ \\(11\\.5\\ ng\\/ml\\;\\ normal\\ 0\\-8\\.5\\ ng\\/ml\\)\\.\ \(0\)\
\-\ normal\\ lrf\\ stimulation\\ labs\\ ruled\\ out\\ precocious\\ puberty\\.\\ csf\\ studies\\ ruled\\ out\\ a\\ germ\\ cell\\ tumor\\ for\\ the\\ intrasellar\\ cyst\\.\\ \\ no\\ calcifications\\,\\ which\\ is\\ common\\ in\\ craniopharyngioma\\,\\ and\\ the\\ absence\\ of\\ a\\ suprasellar\\ lesion\\ rule\\-out\\ craniopharyngioma\\.\\ \\ no\\ treatment\\ is\\ needed\\ if\\ there\\ is\\ no\\ adenoma\\.\\ \\ an\\ mri\\ every\\ year\\ is\\ required\\ to\\ ensure\\ no\\ significant\\ growth\\ has\\ occurred\\.\ \(0\)\
\-\ the\\ first\\ mri\\ showed\\ a\\ pituitary\\ mass\\ of\\ 7\\.5\\ x\\ 4\\.8\\ x\\ 4\\.3\\ mm\\ in\\ height\\,\\ transverse\\,\\ and\\ ap\\ views\\,\\ respectively\\.\\ by\\ age\\ 6\\,\\ the\\ adenoma\\ has\\ grown\\ to\\ 8\\ x\\ 12\\ x\\ 6\\,\\ but\\ has\\ remained\\ stable\\ since\\.\\ imaging\\ shows\\ no\\ anterior\\ or\\ posterior\\ flattening\\ of\\ the\\ pituitary\\ gland\\.\ \(0\)\
\-\ intrasellar\\ cyst\\ with\\ spurious\\ hyperprolactinemia\ \(0\)\
\-\ \\â\\€\\¢\\ pituitary\\ microadenoma\\ \\(intrasellar\\ pituitary\\ cyst\\)\ \(0\)\
\-\ \\â\\€\\¢\\ rathke\\â\\€\\™s\\ cleft\\ cyst\\ remnant\ \(0\)\
\-\ \\â\\€\\¢\\ precoccious\\ puberty\ \(0\)\
\-\ \\â\\€\\¢\\ craniopharyngioma\ \(0\)\
\-\ 1\\ yr\\ old\\ girl\\ presented\\ with\\ premature\\ thelarche\\ and\\ hypertrichosis\\ on\\ legs\\ during\\ the\\ 1st\\ year\\ wellness\\ checkup\\.\ \(1\)\
\-\ http\\:\\/\\/en\\.wikipedia\\.org\\/wiki\\/thelarche\ \(0\)\
\-\ http\\:\\/\\/en\\.wikipedia\\.org\\/wiki\\/hirsutism\ \(0\)\
\-\ the\\ initial\\ concern\\ in\\ this\\ young\\ child\\ was\\ hyper\\-prolactinemia\\ from\\ a\\ suprasellar\\ mass\\ causing\\ the\\ \\"stalk\\ effect\\"\\.\\ \\ http\\:\\/\\/www\\.ncbi\\.nlm\\.nih\\.gov\\/pmc\\/articles\\/pmc2668659\\/\ \(0\)\
\-\ however\\,\\ the\\ imaging\\ did\\ not\\ show\\ a\\ suprasellar\\ mass\\,\\ and\\ the\\ prolactin\\ elevation\\ was\\ minimal\\.\\ \\ prolactin\\ levels\\ due\\ to\\ the\\ stalk\\ effect\\ are\\ usually\\ lower\\ than\\ produced\\ by\\ a\\ prolactinoma\\.\\ however\\,\\ the\\ values\\ from\\ the\\ stalk\\ effect\\ will\\ still\\ be\\ significantly\\ higher\\ than\\ just\\ the\\ slightly\\ elevated\\ prolactin\\ levels\\ this\\ patient\\ showed\\ \\(anywhere\\ from\ \(0\)\
\-\ 100ng\\/ml\\ to\\ under\\ 250ng\\/ml\\ verses\\ this\\ patient\\'s\\ 23ng\\/ml\\)\\.\\ \ \(1\)\
\-\ after\\ discussing\\ this\\ case\\ with\\ a\\ pediatric\\ endocrinologist\\,\\ his\\ top\\ theory\\ was\\ the\\ stress\\ caused\\ to\\ the\\ patient\\.\\ it\\ could\\ be\\ due\\ to\\ the\\ child\\&\\#39\\;s\\ environment\\ at\\ home\\,\\ or\\ the\\ fact\\ the\\ she\ \(0\)\
\-\ just\\ had\\ about\\ 10\\ immunization\\ shots\\ \\(1\\ year\\ check\\-ups\\ are\\ the\\ worst\\)\\.\ \(1\)\
\-\ lastly\\,\\ regarding\\ the\\ ddx\\.\\ i\\ was\\ looking\\ into\\ distinguishing\\ the\\ cysts\\ from\\ the\\ adenoma\\.\\ one\\ thought\\ i\\ had\\ was\\ that\\ the\\ growth\\ of\\ the\\ cyst\\ would\\ be\\ slower\\ than\\ the\\ adenoma\\ presented\\.\\ \ \(0\)\
\-\ followup\\ of\\ the\\ child\\,\\ for\\ early\\ detection\\ of\\ any\\ visual\\ disturbance\\,\\ will\\ prevent\\ loss\\ of\\ sight\\ in\\ the\\ event\\ that\\ the\\ lesion\\ grows\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ the\\:\\ 0\\.26460886269271167\ \(0\)\
\-\ prolactin\\:\\ 0\\.2558338018490708\ \(0\)\
\-\ pituitary\\:\\ 0\\.19113002916462218\ \(0\)\
\-\ adenoma\\:\\ 0\\.16519526890208414\ \(0\)\
\-\ levels\\:\\ 0\\.16427094048693047\ \(0\)\
\-\ intrasellar\\:\\ 0\\.1637437695614526\ \(0\)\
\-\ puberty\\:\\ 0\\.1535002811094425\ \(0\)\
\-\ stalk\\:\\ 0\\.14377368221191547\ \(0\)\
\-\ out\\:\\ 0\\.13619952134600433\ \(0\)\
\-\ lrf\\:\\ 0\\.13254709654117552\ \(0\)\
\-\ thelarche\\:\\ 0\\.13254709654117552\ \(0\)\
\-\ suprasellar\\:\\ 0\\.12196542271592736\ \(0\)\
\-\ craniopharyngioma\\:\\ 0\\.12012253773823554\ \(0\)\
\-\ cyst\\:\\ 0\\.11952958701995009\ \(0\)\
\-\ estradiol\\:\\ 0\\.11923370497481746\ \(0\)\
\-\ was\\:\\ 0\\.11554143104862966\ \(0\)\
\-\ elevated\\:\\ 0\\.11300415284337405\ \(0\)\
\-\ precocious\\:\\ 0\\.1091625130409684\ \(0\)\
\-\ child\\:\\ 0\\.10291175514612452\ \(0\)\
\-\ rule\\:\\ 0\\.09867236043363127\ \(0\)\
\-\ to\\:\\ 0\\.09324203447670544\ \(0\)\
\-\ http\\:\\ 0\\.09191269257422988\ \(0\)\
\-\ stimulation\\:\\ 0\\.09138147374446731\ \(0\)\
\-\ effect\\:\\ 0\\.08721143467480516\ \(0\)\
\-\ ruled\\:\\ 0\\.08288869443918376\ \(0\)\
\-\ had\\:\\ 0\\.08259017751780952\ \(0\)\
\-\ however\\:\\ 0\\.07358508839773648\ \(0\)\
\-\ ordered\\:\\ 0\\.07281750250533468\ \(0\)\
\-\ than\\:\\ 0\\.0704755648848576\ \(0\)\
\-\ growth\\:\\ 0\\.06834285084222462\ \(0\)\
\-\ normal\\:\\ 0\\.06768070504927201\ \(0\)\
\-\ no\\:\\ 0\\.0673810819516164\ \(0\)\
\-\ just\\:\\ 0\\.06630454838279555\ \(0\)\
\-\ spurious\\:\\ 0\\.06627354827058776\ \(0\)\
\-\ precoccious\\:\\ 0\\.06627354827058776\ \(0\)\
\-\ hypertrichosis\\:\\ 0\\.06627354827058776\ \(0\)\
\-\ from\\:\\ 0\\.06583479824177615\ \(0\)\
\-\ slightly\\:\\ 0\\.06465248860542251\ \(0\)\
\-\ mri\\:\\ 0\\.0638167509212449\ \(0\)\
\-\ leuprolide\\:\\ 0\\.06332791346115423\ \(0\)\
\-\ wellness\\:\\ 0\\.06332791346115423\ \(0\)\
\-\ shots\\:\\ 0\\.06332791346115423\ \(0\)\
\-\ checkup\\:\\ 0\\.061237952303663225\ \(0\)\
\-\ verses\\:\\ 0\\.061237952303663225\ \(0\)\
\-\ and\\:\\ 0\\.05994325946010119\ \(0\)\
\-\ acetate\\:\\ 0\\.05961685248740873\ \(0\)\
\-\ prolactinoma\\:\\ 0\\.05961685248740873\ \(0\)\
\-\ endocrinologist\\:\\ 0\\.05961685248740873\ \(0\)\
\-\ sight\\:\\ 0\\.05961685248740873\ \(0\)\
\-\ hyperprolactinemia\\:\\ 0\\.05829231749422969\ \(0\)\
\-\ discussing\\:\\ 0\\.05829231749422969\ \(0\)\
\-\ immunization\\:\\ 0\\.05829231749422969\ \(0\)\
\-\ synthetic\\:\\ 0\\.05717243911427329\ \(0\)\
\-\ this\\:\\ 0\\.0569598114518358\ \(0\)\
\-\ has\\:\\ 0\\.05678743886234926\ \(0\)\
\-\ of\\:\\ 0\\.05676905674261659\ \(0\)\
\-\ slower\\:\\ 0\\.05534668268479614\ \(0\)\
\-\ showed\\:\\ 0\\.05520557850688183\ \(0\)\
\-\ microadenoma\\:\\ 0\\.0545812565204842\ \(0\)\
\-\ environment\\:\\ 0\\.0545812565204842\ \(0\)\
\-\ patient\\:\\ 0\\.053915006659744524\ \(0\)\
\-\ will\\:\\ 0\\.05334536847484573\ \(0\)\
\-\ lastly\\:\\ 0\\.052675224916993654\ \(0\)\
\-\ grows\\:\\ 0\\.052675224916993654\ \(0\)\
\-\ grown\\:\\ 0\\.05213684314734875\ \(0\)\
\-\ remnant\\:\\ 0\\.05213684314734875\ \(0\)\
\-\ theory\\:\\ 0\\.05213684314734875\ \(0\)\
\-\ disturbance\\:\\ 0\\.051166760369814164\ \(0\)\
\-\ be\\:\\ 0\\.05043315062827357\ \(0\)\
\-\ distinguishing\\:\\ 0\\.05031108671787161\ \(0\)\
\-\ presented\\:\\ 0\\.048332355855833724\ \(0\)\
\-\ anywhere\\:\\ 0\\.048221125560380614\ \(0\)\
\-\ due\\:\\ 0\\.047642390804144334\ \(0\)\
\-\ an\\:\\ 0\\.04754096153271045\ \(0\)\
\-\ mass\\:\\ 0\\.04748833052913726\ \(0\)\
\-\ worst\\:\\ 0\\.047365451908438064\ \(0\)\
\-\ yr\\:\\ 0\\.047101247180424216\ \(0\)\
\-\ looking\\:\\ 0\\.04636181327757574\ \(0\)\
\-\ is\\:\\ 0\\.045395849357250544\ \(0\)\
\-\ rathke\\:\\ 0\\.04527549075094708\ \(0\)\
\-\ consulted\\:\\ 0\\.04488270161610348\ \(0\)\
\-\ alpha\\:\\ 0\\.04365439093469257\ \(0\)\
\-\ imaging\\:\\ 0\\.04355753747823049\ \(0\)\
\-\ regarding\\:\\ 0\\.043494717928533815\ \(0\)\
\-\ ensure\\:\\ 0\\.04318552959345608\ \(0\)\
\-\ 1st\\:\\ 0\\.04318552959345608\ \(0\)\
\-\ detection\\:\\ 0\\.04318552959345608\ \(0\)\
\-\ respectively\\:\\ 0\\.04288896477038062\ \(0\)\
\-\ hormone\\:\\ 0\\.04219655258074754\ \(0\)\
\-\ produced\\:\\ 0\\.04219655258074754\ \(0\)\
\-\ event\\:\\ 0\\.04132621731065121\ \(0\)\
\-\ in\\:\\ 0\\.04123693216716533\ \(0\)\
\-\ remained\\:\\ 0\\.040982933166890084\ \(0\)\
\-\ flattening\\:\\ 0\\.0408720175875685\ \(0\)\
\-\ premature\\:\\ 0\\.0408720175875685\ \(0\)\
\-\ legs\\:\\ 0\\.040762769975038624\ \(0\)\
\-\ top\\:\\ 0\\.04044455139724518\ \(0\)\
\-\ every\\:\\ 0\\.040139688652845645\ \(0\)\
\-\ occurred\\:\\ 0\\.040040845912745184\ \(0\)\
\-\ height\\:\\ 0\\.0397521392076121\ \(0\)\
\-\ fact\\:\\ 0\\.0397521392076121\ \(0\)\
\-\ lesion\\:\\ 0\\.039735694928017165\ \(0\)\
\-\ ddx\\:\\ 0\\.03938422113207998\ \(0\)\
\-\ returned\\:\\ 0\\.03894907135634513\ \(0\)\
\-\ significantly\\:\\ 0\\.03894907135634513\ \(0\)\
\-\ germ\\:\\ 0\\.038699967089659525\ \(0\)\
\-\ fetal\\:\\ 0\\.03845912196160928\ \(0\)\
\-\ protein\\:\\ 0\\.03845912196160928\ \(0\)\
\-\ year\\:\\ 0\\.03831411337097951\ \(0\)\
\-\ values\\:\\ 0\\.03822600583292444\ \(0\)\
\-\ concern\\:\\ 0\\.03800013802410974\ \(0\)\
\-\ prevent\\:\\ 0\\.03800013802410974\ \(0\)\
\-\ elevation\\:\\ 0\\.03778108134803674\ \(0\)\
\-\ higher\\:\\ 0\\.037638629149989715\ \(0\)\
\-\ cleft\\:\\ 0\\.03743005513072477\ \(0\)\
\-\ pediatric\\:\\ 0\\.03709521110331163\ \(0\)\
\-\ still\\:\\ 0\\.0367127633642775\ \(0\)\
\-\ home\\:\\ 0\\.03665093465636463\ \(0\)\
\-\ followup\\:\\ 0\\.03658962771591918\ \(0\)\
\-\ that\\:\\ 0\\.035967879265969345\ \(0\)\
\-\ thought\\:\\ 0\\.035781592459789\ \(0\)\
\-\ visual\\:\\ 0\\.03535724824172233\ \(0\)\
\-\ by\\:\\ 0\\.03519669933336589\ \(0\)\
\-\ clinic\\:\\ 0\\.03490773399402254\ \(0\)\
\-\ 39\\:\\ 0\\.03443887265278606\ \(0\)\
\-\ under\\:\\ 0\\.03430391838204151\ \(0\)\
\-\ needed\\:\\ 0\\.034215321804389465\ \(0\)\
\-\ stress\\:\\ 0\\.034215321804389465\ \(0\)\
\-\ young\\:\\ 0\\.03417142542111231\ \(0\)\
\-\ causing\\:\\ 0\\.03404130559647501\ \(0\)\
\-\ test\\:\\ 0\\.03370529984693109\ \(0\)\
\-\ gland\\:\\ 0\\.03366437112273499\ \(0\)\
\-\ mildly\\:\\ 0\\.0334631164432338\ \(0\)\
\-\ as\\:\\ 0\\.033296825570540825\ \(0\)\
\-\ caused\\:\\ 0\\.033228746785199055\ \(0\)\
\-\ absence\\:\\ 0\\.03303905378041683\ \(0\)\
\-\ stable\\:\\ 0\\.03278153919868054\ \(0\)\
\-\ csf\\:\\ 0\\.0327454853811122\ \(0\)\
\-\ views\\:\\ 0\\.03270960960781285\ \(0\)\
\-\ with\\:\\ 0\\.032458843565995994\ \(0\)\
\-\ transverse\\:\\ 0\\.03192988259374629\ \(0\)\
\-\ minimal\\:\\ 0\\.031615338689440095\ \(0\)\
\-\ are\\:\\ 0\\.03145012396456838\ \(0\)\
\-\ cysts\\:\\ 0\\.03140299035572191\ \(0\)\
\-\ at\\:\\ 0\\.03130575427344788\ \(0\)\
\-\ about\\:\\ 0\\.03102437650211603\ \(0\)\
\-\ studies\\:\\ 0\\.03039935172485958\ \(0\)\
\-\ calcifications\\:\\ 0\\.030244775056566368\ \(0\)\
\-\ could\\:\\ 0\\.030143521440804077\ \(0\)\
\-\ since\\:\\ 0\\.03001890724775166\ \(0\)\
\-\ early\\:\\ 0\\.02987213802709801\ \(0\)\
\-\ ap\\:\\ 0\\.02975205546948831\ \(0\)\
\-\ did\\:\\ 0\\.029728275319517498\ \(0\)\
\-\ mm\\:\\ 0\\.02965739837363163\ \(0\)\
\-\ required\\:\\ 0\\.029587206239861975\ \(0\)\
\-\ would\\:\\ 0\\.02933548618467391\ \(0\)\
\-\ girl\\:\\ 0\\.029070478224935054\ \(0\)\
\-\ or\\:\\ 0\\.028833331874890736\ \(0\)\
\-\ labs\\:\\ 0\\.028710864496228436\ \(0\)\
\-\ 12\\:\\ 0\\.028328945974410297\ \(0\)\
\-\ 15\\:\\ 0\\.02800345781349229\ \(0\)\
\-\ first\\:\\ 0\\.027966106423607473\ \(0\)\
\-\ initial\\:\\ 0\\.027800361683430922\ \(0\)\
\-\ any\\:\\ 0\\.026782640510083958\ \(0\)\
\-\ show\\:\\ 0\\.026307846274006168\ \(0\)\
\-\ during\\:\\ 0\\.026248782295584833\ \(0\)\
\-\ usually\\:\\ 0\\.026088789597933166\ \(0\)\
\-\ age\\:\\ 0\\.026017214345772005\ \(0\)\
\-\ loss\\:\\ 0\\.02524751600884097\ \(0\)\
\-\ his\\:\\ 0\\.025133106883248935\ \(0\)\
\-\ for\\:\\ 0\\.025121037422967552\ \(0\)\
\-\ level\\:\\ 0\\.025032900752072047\ \(0\)\
\-\ she\\:\\ 0\\.024668976788893706\ \(0\)\
\-\ time\\:\\ 0\\.024563261966420516\ \(0\)\
\-\ shows\\:\\ 0\\.024322416838370265\ \(0\)\
\-\ 10\\:\\ 0\\.024232726448192438\ \(0\)\
\-\ if\\:\\ 0\\.024078384360029025\ \(0\)\
\-\ significant\\:\\ 0\\.02392725318828102\ \(0\)\
\-\ one\\:\\ 0\\.023727049427989325\ \(0\)\
\-\ cell\\:\\ 0\\.023706292758642267\ \(0\)\
\-\ common\\:\\ 0\\.0235019240267507\ \(0\)\
\-\ anterior\\:\\ 0\\.023138361103515793\ \(0\)\
\-\ into\\:\\ 0\\.02202944436928962\ \(0\)\
\-\ tumor\\:\\ 0\\.021676167597273553\ \(0\)\
\-\ posterior\\:\\ 0\\.021429617384216306\ \(0\)\
\-\ were\\:\\ 0\\.021361756523416316\ \(0\)\
\-\ it\\:\\ 0\\.0212131863286603\ \(0\)\
\-\ lower\\:\\ 0\\.021176513715049805\ \(0\)\
\-\ case\\:\\ 0\\.02081962322808547\ \(0\)\
\-\ but\\:\\ 0\\.02049275290566161\ \(0\)\
\-\ after\\:\\ 0\\.020103819930467677\ \(0\)\
\-\ well\\:\\ 0\\.020066047769140883\ \(0\)\
\-\ treatment\\:\\ 0\\.019740656707161817\ \(0\)\
\-\ which\\:\\ 0\\.018843739521827132\ \(0\)\
\-\ there\\:\\ 0\\.01648933673533619\ \(0\)\
\-\ not\\:\\ 0\\.016360011751037132\ \(0\)\
\-\ on\\:\\ 0\\.012515962734166365\ \(0\)\
\-\ old\\:\\ 0\\.012264937198539985\ \(0\)\
